Lu Xiaolu was engrossed, his heart surging, not knowing what to say.
Yang Ping turned around and looked out the window. The sunshine had already entered the courtyard, and the leaves of the ginkgo tree rustled in the wind.
"It means that the research we've been doing over the past few years is not about creating new therapies," he said. "It's about discovering the body's inherent capabilities. All three of my theories are merely blind men feeling an elephant."
The whole morning, Yang Ping's office had turned into a temporary command center.
Manstein brought in a laptop, pulling up all the mass spectrometry data on unknown factors from the past three years. Weber brought the original records of stem cell differentiation, over twelve hundred cell culture logs. Tang Shun opened the database of the K therapy clinical trials, containing follow-up data for more than five hundred patients.
